Q4 2024 Cascades Inc Earnings Call Transcript
Key Points
- Cascades Inc (CADNF) reported a 6% year-over-year increase in sales for Q4 2024, driven by favorable selling prices and exchange rates.
- Consolidated EBITDA increased by 20% year-over-year, reflecting stronger contributions from packaging activities.
- The Containerboard segment saw a 16% sequential increase in EBITDA, marking the fourth consecutive quarter of improvement.
- The Specialty Products business delivered solid results with a 9% year-over-year sales increase and a 47% improvement in EBITDA.
- The company has implemented strategic initiatives to mitigate potential tariff impacts, including changes to raw material sourcing and production reallocation.
- Cascades Inc (CADNF) reported a net loss per share of $0.13 for Q4 2024, compared to a net loss of $0.57 per share in the same period last year.
- The Tissue business experienced a year-over-year EBITDA decrease of $16 million, mainly due to higher raw material costs.
- Corporate activities saw an $11 million negative impact due to unfavorable exchange rate variations and higher health insurance costs for US employees.
- The company faces potential risks from bilateral tariffs, which could impact approximately 15% of its revenues.
- Net debt increased by $57 million in Q4, raising leverage to 4.2x, up from 3.4x at the end of 2023.
Good morning. My name is Silvie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Cascades fourth quarter 2024 financial results conference call. (Operator Instructions)
I will now pass the call to Jennifer Aitken, Director of Investor Relations for Cascades. Please go ahead, Ms. Aitken.
Thank you, Silvie. Good morning, everyone, and thank you for joining our fourth quarter 2024 conference call. We will begin with an overview of our operational and financial results, followed by some concluding remarks, after which we will begin the question period. Today's speakers will be Hugues Simon, President and CEO; and Allan Hogg, CFO.
Also joining us for the question period at the end of the call are Jean-David Tardif, Executive Vice President of Packaging; and Geron Paige, Executive Vice President, Tissue. Before I turn the call over to my colleagues, I would like to highlight that certain statements made during this call will discuss
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
